ASCLETIS ANNOUNCES ORAL DISCUSSION OF ASC36_35 FDC PRECLINICAL DATA DEMONSTRATING SUPERIOR WEIGHT LOSS TO ELORALINTIDE/TIRZEPATIDE COMBINATION AT THE 62ND EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING

Reuters · 2d ago

Please log in to view news